Last reviewed · How we verify

NCT04737447: WBVT

Whole Body Vibration Training in the Treatment for Children's Incontinence - a Randomized-Controlled Trial

Completed NA Last updated 9 December 2024
What this trial tests

NA trial testing Whole Body Vibration Training in Incontinence, Urinary in 40 participants. Completed in 31 January 2023.

Timeline
15 January 2019
Primary endpoint
31 January 2023
31 January 2023

Quick facts

Lead sponsorUniversity Children's Hospital, Zurich
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment40
Start date15 January 2019
Primary completion31 January 2023
Estimated completion31 January 2023
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

University Children's Hospital, Zurich

Who can join

Adults 7 to 16, any sex, with Incontinence, Urinary. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The determined study category is a prospective clinical randomized controlled study to evaluate the effect of WBVT in combination with urophysiotherapy to playfully expand the therapeutic options for children and adolescents with incontinence. This will be the first time use of WBVT for treating incontinence in children.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Whole Body Vibration Training

Trials testing the same drug.

Other recruiting trials for Incontinence, Urinary

Currently open trials in the same condition.

Other University Children's Hospital, Zurich trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04737447.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing